Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartate:glutamate, proton antiporter activity	SLC25A12 SLC25A13	4.95e-05	2	141	2	GO:0000515
GeneOntologyMolecularFunction	3-sulfino-L-alanine: proton, glutamate antiporter activity	SLC25A12 SLC25A13	4.95e-05	2	141	2	GO:0000514
GeneOntologyMolecularFunction	kynurenine-oxoglutarate transaminase activity	AADAT GOT2	2.94e-04	4	141	2	GO:0016212
GeneOntologyMolecularFunction	ATP-dependent activity	RAD51 RAD51D ATP6V1B2 DYNC2H1 MYH7B ZGRF1 RECQL TOP6BL ATP13A2 MDN1 KIF15 DDX60L MOV10	4.19e-04	614	141	13	GO:0140657
GeneOntologyMolecularFunction	antiporter activity	SLC26A5 SLC44A4 SLC25A12 CLCN6 SLC41A3 SLC25A13	4.46e-04	138	141	6	GO:0015297
GeneOntologyMolecularFunction	amino acid:monoatomic cation antiporter activity	SLC25A12 SLC25A13	4.88e-04	5	141	2	GO:0140848
Domain	-	HSPG2 FAT3 LAMA4 ADGRV1 ADGRG4 FAT2	8.33e-05	95	141	6	2.60.120.200
Domain	Ig_E-set	MYCBP2 EBF3 EBF1 TGM4 MET A2ML1	1.38e-04	104	141	6	IPR014756
Domain	Ldl_recept_b	LRP6 NID1 SORL1	1.44e-04	14	141	3	PF00058
Domain	LDLRB	LRP6 NID1 SORL1	1.44e-04	14	141	3	PS51120
Domain	LY	LRP6 NID1 SORL1	1.79e-04	15	141	3	SM00135
Domain	LDLR_classB_rpt	LRP6 NID1 SORL1	1.79e-04	15	141	3	IPR000033
Domain	LAM_G_DOMAIN	HSPG2 FAT3 LAMA4 FAT2	1.88e-04	38	141	4	PS50025
Domain	CADHERIN_1	DCHS2 CDHR2 CDHR3 FAT3 PCDHB4 FAT2	2.17e-04	113	141	6	PS00232
Domain	Cadherin	DCHS2 CDHR2 CDHR3 FAT3 PCDHB4 FAT2	2.17e-04	113	141	6	PF00028
Domain	CADHERIN_2	DCHS2 CDHR2 CDHR3 FAT3 PCDHB4 FAT2	2.27e-04	114	141	6	PS50268
Domain	-	DCHS2 CDHR2 CDHR3 FAT3 PCDHB4 FAT2	2.27e-04	114	141	6	2.60.40.60
Domain	Laminin_G_2	HSPG2 FAT3 LAMA4 FAT2	2.30e-04	40	141	4	PF02210
Domain	CA	DCHS2 CDHR2 CDHR3 FAT3 PCDHB4 FAT2	2.38e-04	115	141	6	SM00112
Domain	Cadherin-like	DCHS2 CDHR2 CDHR3 FAT3 PCDHB4 FAT2	2.50e-04	116	141	6	IPR015919
Domain	Cadherin	DCHS2 CDHR2 CDHR3 FAT3 PCDHB4 FAT2	2.74e-04	118	141	6	IPR002126
Domain	LamG	HSPG2 FAT3 LAMA4 FAT2	3.34e-04	44	141	4	SM00282
Domain	SHR-BD	VPS13D VPS13B	3.36e-04	4	141	2	IPR009543
Domain	COE	EBF3 EBF1	3.36e-04	4	141	2	PS01345
Domain	Transcription_factor_COE	EBF3 EBF1	3.36e-04	4	141	2	IPR003523
Domain	VPS13_C	VPS13D VPS13B	3.36e-04	4	141	2	PF16909
Domain	COE_HLH	EBF3 EBF1	3.36e-04	4	141	2	IPR032201
Domain	COE_DBD	EBF3 EBF1	3.36e-04	4	141	2	IPR032200
Domain	Transcription_factor_COE_CS	EBF3 EBF1	3.36e-04	4	141	2	IPR018350
Domain	COE1_HLH	EBF3 EBF1	3.36e-04	4	141	2	PF16423
Domain	COE1_DBD	EBF3 EBF1	3.36e-04	4	141	2	PF16422
Domain	VPS13_C	VPS13D VPS13B	3.36e-04	4	141	2	IPR031645
Domain	SHR-BD	VPS13D VPS13B	3.36e-04	4	141	2	PF06650
Domain	NA-bd_OB-fold	RNGTT POLR2G SRBD1 FXR1 AIM2	4.13e-04	83	141	5	IPR012340
Domain	-	HSPG2 MYLK CD300LF MYCBP2 EBF3 CADM4 EBF1 F3 TGM4 MET IGSF22 CADM1 HCFC1 SORL1	5.00e-04	663	141	14	2.60.40.10
Domain	zf-RanBP	RYBP TAF15 FUS	5.84e-04	22	141	3	PF00641
Domain	ZnF_RBZ	RYBP TAF15 FUS	6.68e-04	23	141	3	SM00547
Domain	ZF_RANBP2_2	RYBP TAF15 FUS	6.68e-04	23	141	3	PS50199
Domain	ZF_RANBP2_1	RYBP TAF15 FUS	7.59e-04	24	141	3	PS01358
Domain	Rad51_DMC1_RadA	RAD51 RAD51D	8.32e-04	6	141	2	IPR033925
Domain	PKD/REJ-like	KIAA0319L PKDREJ	8.32e-04	6	141	2	IPR002859
Domain	REJ	KIAA0319L PKDREJ	8.32e-04	6	141	2	PF02010
Domain	DNA_recomb/repair_RecA-like	RAD51 RAD51D	8.32e-04	6	141	2	IPR016467
Domain	Znf_RanBP2	RYBP TAF15 FUS	8.58e-04	25	141	3	IPR001876
Domain	Ig-like_fold	HSPG2 MYLK CD300LF MYCBP2 EBF3 CADM4 EBF1 F3 TGM4 MET IGSF22 CADM1 HCFC1 SORL1	9.22e-04	706	141	14	IPR013783
Domain	Laminin_G	HSPG2 FAT3 LAMA4 FAT2	9.63e-04	58	141	4	IPR001791
Domain	IPT	EBF3 EBF1 MET	1.08e-03	27	141	3	SM00429
Domain	DNA_recomb/repair_Rad51_C	RAD51 RAD51D	1.16e-03	7	141	2	IPR013632
Domain	Arm_3	KPNA5 KPNA2	1.16e-03	7	141	2	PF16186
Domain	RecA_ATP-bd	RAD51 RAD51D	1.16e-03	7	141	2	IPR020588
Domain	RECA_2	RAD51 RAD51D	1.16e-03	7	141	2	PS50162
Domain	Importing_su_alpha	KPNA5 KPNA2	1.16e-03	7	141	2	IPR024931
Domain	IBB	KPNA5 KPNA2	1.16e-03	7	141	2	PF01749
Domain	Rad51	RAD51 RAD51D	1.16e-03	7	141	2	PF08423
Domain	Arm_3	KPNA5 KPNA2	1.16e-03	7	141	2	IPR032413
Domain	Cadherin_CS	DCHS2 CDHR2 FAT3 PCDHB4 FAT2	1.42e-03	109	141	5	IPR020894
Domain	Chorein_N	VPS13D VPS13B	1.54e-03	8	141	2	PF12624
Domain	MacrogloblnA2_thiol-ester-bond	A2ML1 C3	1.54e-03	8	141	2	IPR019565
Domain	IBB	KPNA5 KPNA2	1.54e-03	8	141	2	PS51214
Domain	VPS13_N	VPS13D VPS13B	1.54e-03	8	141	2	IPR026854
Domain	S1	POLR2G SRBD1	1.54e-03	8	141	2	PF00575
Domain	Thiol-ester_cl	A2ML1 C3	1.54e-03	8	141	2	PF10569
Domain	MacrogloblnA2_CS	A2ML1 C3	1.54e-03	8	141	2	IPR019742
Domain	A2M_N_2	A2ML1 C3	1.54e-03	8	141	2	SM01359
Domain	-	A2ML1 C3	1.54e-03	8	141	2	2.60.40.690
Domain	A2M_recep	A2ML1 C3	1.54e-03	8	141	2	SM01361
Domain	A2M	A2ML1 C3	1.54e-03	8	141	2	SM01360
Domain	TIG	EBF3 EBF1 MET	1.62e-03	31	141	3	PF01833
Domain	IPT	EBF3 EBF1 MET	1.78e-03	32	141	3	IPR002909
Domain	Importin-a_IBB	KPNA5 KPNA2	1.97e-03	9	141	2	IPR002652
Domain	EGF	HSPG2 FAT3 LAMA4 FAT2 LRP6 NID1 SORL1	2.07e-03	235	141	7	SM00181
Domain	EGF_3	HSPG2 FAT3 FAT2 LRP6 NID1 ADAM2 SORL1	2.07e-03	235	141	7	PS50026
Domain	GPS	ADGRV1 PKDREJ ADGRG4	2.12e-03	34	141	3	SM00303
Domain	-	TAF15 FUS	2.45e-03	10	141	2	4.10.1060.10
Domain	A2M	A2ML1 C3	2.45e-03	10	141	2	PF00207
Domain	A2M_N_2	A2ML1 C3	2.45e-03	10	141	2	IPR011625
Domain	A2M_comp	A2ML1 C3	2.45e-03	10	141	2	IPR011626
Domain	A2M_recep	A2ML1 C3	2.45e-03	10	141	2	PF07677
Domain	A2M_comp	A2ML1 C3	2.45e-03	10	141	2	PF07678
Domain	A2M_N	A2ML1 C3	2.45e-03	10	141	2	PF01835
Domain	A2M_N	A2ML1 C3	2.45e-03	10	141	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	A2ML1 C3	2.45e-03	10	141	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	A2ML1 C3	2.45e-03	10	141	2	PS00477
Domain	A2M_N_2	A2ML1 C3	2.45e-03	10	141	2	PF07703
Domain	Macroglobln_a2	A2ML1 C3	2.45e-03	10	141	2	IPR001599
Domain	GPS	ADGRV1 PKDREJ ADGRG4	2.71e-03	37	141	3	IPR000203
Domain	EGF-like_dom	HSPG2 FAT3 LAMA4 FAT2 LRP6 NID1 SORL1	2.87e-03	249	141	7	IPR000742
Domain	-	LRP6 NID1 SORL1	3.16e-03	39	141	3	2.120.10.30
Domain	EGF_1	HSPG2 FAT3 LAMA4 FAT2 LRP6 NID1 ADAM2	3.27e-03	255	141	7	PS00022
Domain	LDLR_class-A_CS	HSPG2 LRP6 SORL1	3.39e-03	40	141	3	IPR023415
Domain	S1	POLR2G SRBD1	3.55e-03	12	141	2	SM00316
Domain	S1_dom	POLR2G SRBD1	3.55e-03	12	141	2	IPR022967
Domain	S1_domain	POLR2G SRBD1	3.55e-03	12	141	2	IPR003029
Domain	-	A2ML1 C3	3.55e-03	12	141	2	1.50.10.20
Domain	EGF-like_CS	HSPG2 FAT3 LAMA4 FAT2 LRP6 NID1 SORL1	3.71e-03	261	141	7	IPR013032
Domain	EGF_2	HSPG2 FAT3 FAT2 LRP6 NID1 ADAM2 SORL1	4.03e-03	265	141	7	PS01186
Domain	Ldl_recept_a	HSPG2 LRP6 SORL1	4.74e-03	45	141	3	PF00057
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 MDN1	4.85e-03	14	141	2	IPR011704
Domain	Neurexin-like	CADM4 CADM1	4.85e-03	14	141	2	IPR003585
Domain	4.1m	CADM4 CADM1	4.85e-03	14	141	2	SM00294
Domain	AAA_5	DYNC2H1 MDN1	4.85e-03	14	141	2	PF07728
Domain	6-blade_b-propeller_TolB-like	LRP6 NID1 SORL1	5.04e-03	46	141	3	IPR011042
Domain	-	HSPG2 LRP6 SORL1	5.04e-03	46	141	3	4.10.400.10
Domain	FN3_dom	MYLK KIAA0319L F3 IGSF22 HCFC1 SORL1	5.13e-03	209	141	6	IPR003961
Domain	LDLRA_1	HSPG2 LRP6 SORL1	5.68e-03	48	141	3	PS01209
Domain	LDrepeatLR_classA_rpt	HSPG2 LRP6 SORL1	6.02e-03	49	141	3	IPR002172
Pathway	REACTOME_MALATE_ASPARTATE_SHUTTLE	SLC25A12 SLC25A13 GOT2	2.74e-05	9	99	3	M48269
Pathway	REACTOME_MALATE_ASPARTATE_SHUTTLE	SLC25A12 SLC25A13 GOT2	2.74e-05	9	99	3	MM17242
Pathway	REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM	SLC25A12 SLC25A13 GOT2	5.32e-05	11	99	3	M27836
Pathway	REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM	SLC25A12 SLC25A13 GOT2	7.06e-05	12	99	3	MM15556
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYCBP2 UGGT1 CKAP5 RECQL FRYL HEATR1 MYEF2 FXR1 MDN1 SLC25A13 TAF15 LTF FUS UTRN CLUH HCFC1 EPB41L2 MOV10	2.71e-10	653	144	18	22586326
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ATP6V1B2 MYCBP2 IARS1 UGGT1 PPP1R9A CKAP5 HEATR1 MYEF2 FXR1 MDN1 SLC25A13 PRKAR1A TAF15 FUS HSD17B4 UTRN EPB41L2 GOT2 KPNA2	5.22e-08	1024	144	19	24711643
Pubmed	Selective interactions of hnRNP M isoforms with the TET proteins TAF15 and TLS/FUS.	HNRNPM TAF15 FUS	6.95e-08	3	144	3	24474660
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYCBP2 EBF3 PPP1R9A HNRNPM CKAP5 PPP6R1 ARMCX4 TMEM132B MYEF2 FXR1 MDN1 KIF15 SH3D19 PRKAR1A TAF15 FUS SSH2 EPB41L2	1.08e-07	963	144	18	28671696
Pubmed	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.	IARS1 UGGT1 HNRNPM FXR1 SLC25A12 SLC25A13 A2ML1 C3 LTF HSD17B4 GOT2	1.32e-07	327	144	11	31409639
Pubmed	Global Interactome Mapping of Mitochondrial Intermembrane Space Proteases Identifies a Novel Function for HTRA2.	NRDC UGGT1 RTN4IP1 CPD NDUFS2 FXR1 MDN1 SLC25A12 GUCY1B1 SLC25A13 HSD17B4 UTRN CLUH	2.56e-07	515	144	13	31617661
Pubmed	Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia.	SLC25A12 SLC25A13 GOT2	2.77e-07	4	144	3	14701727
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	RAD51 RAD51D MYCBP2 EBF3 IARS1 UGGT1 HNRNPM FRYL HEATR1 MET PPIG LOXHD1 SLC25A12 PRKAR1A LTF FUS USF1 EPB41L2 GOT2 MOV10	3.74e-07	1284	144	20	17353931
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	NRDC DYNC2H1 IARS1 UGGT1 HNRNPM CKAP5 RECQL HEATR1 NDUFS2 FXR1 MDN1 SLC25A13 PRKAR1A LTF FUS HSD17B4 CLUH HCFC1 EPB41L2 GOT2 KPNA2	4.58e-07	1425	144	21	30948266
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	KPNA5 EBF3 IARS1 CKAP5 RECQL PPP6R1 HEATR1 RFX2 MYEF2 FXR1 MDN1 A2ML1 HCFC1 MOV10 SORL1 KPNA2	5.88e-07	857	144	16	25609649
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	ZGRF1 FAT3 HNRNPM FER1L6 FAT2 FXR1 MDN1 LTF VPS13B	6.27e-07	234	144	9	36243803
Pubmed	Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.	DCHS2 FAT3 FAT2 NR5A1	8.24e-07	18	144	4	33108146
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	DCHS2 NWD1 COL6A6 RECQL VPS13D LOXHD1 MDN1 SLC25A12 KIF15 SLC25A13 NID1 HCFC1	1.20e-06	497	144	12	36774506
Pubmed	A novel receptor tyrosine phosphatase-sigma that is highly expressed in the nervous system.	EBF1 C3 IL5	1.38e-06	6	144	3	8227050
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	MAN2A1 MYLK IARS1 HNRNPM HEATR1 FXR1 SLC25A13 C3 TAF15 DDX60L LTF FUS HSD17B4 UTRN	1.68e-06	711	144	14	33022573
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MICAL1 ATP6V1B2 ACADL NRDC IARS1 PPP1R9A HNRNPM CKAP5 NDUFS2 MYEF2 ADD3 FXR1 SLC25A12 CLCN6 PRKAR1A TAF15 SSH2 UTRN EPB41L2 GOT2	1.99e-06	1431	144	20	37142655
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	DCHS2 FAT3 FAT2	2.40e-06	7	144	3	16059920
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	KPNA5 RNGTT NRDC UGGT1 CKAP5 CPD PPP6R1 HEATR1 ANKRD50 FXR1 NID1 C3 TTC13 UTRN CLUH SORL1	3.07e-06	974	144	16	28675297
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	KPNA5 MYH7B IARS1 UGGT1 HNRNPM MDN1 SLC25A12 SLC25A13 C3 LTF HSD17B4 MOV10 KPNA2	3.22e-06	647	144	13	26618866
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYCBP2 IARS1 HNRNPM CKAP5 RECQL HEATR1 SRBD1 MYEF2 FXR1 MDN1 SLC25A12 SLC25A13 A2ML1 DDX60L LTF UTRN EPB41L2 GOT2 MOV10	3.43e-06	1353	144	19	29467282
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP6V1B2 AFTPH MYCBP2 DYNC2H1 UGGT1 HNRNPM RTN4IP1 CPD PPP6R1 HEATR1 NDUFS2 ADD3 MET MDN1 PRKAR1A TAF15 TTC13 CLUH VPS13B EPB41L2	3.54e-06	1487	144	20	33957083
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	ATP6V1B2 MAN2A1 NRDC MYCBP2 IARS1 UGGT1 RECQL CPD MET PRKAR1A C3 TTC13 FUS CLUH HCFC1 EPB41L2 GOT2 KPNA2	7.45e-06	1297	144	18	33545068
Pubmed	A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function.	ADGRV1 LOXHD1 PGAP1	8.17e-06	10	144	3	17329413
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	HSPG2 IARS1 UGGT1 HNRNPM CKAP5 CPD NDUFS2 MET SLC25A12 SLC25A13 TTC13 SORL1	1.01e-05	613	144	12	22268729
Pubmed	Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).	HSPG2 ATP6V1B2 MAN2A1 UGGT1 LAMA4 CPD FAT2 A2ML1 LTF MUC5AC	1.02e-05	417	144	10	19199708
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	IARS1 HNRNPM CKAP5 SLC25A13 TAF15 LTF EPB41L2	1.03e-05	179	144	7	36261009
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	ACADL MYH7B RTN4IP1 NDUFS2 FSIP2 SLC25A12 SLC25A13 VPS13B GOT2	1.06e-05	331	144	9	29199018
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	RNGTT COL28A1 IARS1 HNRNPM CKAP5 PPP6R1 CSMD2 TMEM132B NDUFS2 LOXHD1 MDN1 UTRN EPB41L2	1.28e-05	736	144	13	29676528
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	AFTPH MYCBP2 CKAP5 FRYL FSIP2 VPS13D FXR1 MDN1 SH3D19 SSH2 RGL2 UTRN GARRE1 EPB41L2	1.48e-05	861	144	14	36931259
Pubmed	Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function.	HSPG2 LAMA4 NID1	1.49e-05	12	144	3	16750824
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	IARS1 HNRNPM CKAP5 HEATR1 ADD3 FXR1 MDN1 SLC25A13 FUS HSD17B4 EPB41L2 KPNA2	1.51e-05	638	144	12	33239621
Pubmed	Calcium-induced conformational changes of the regulatory domain of human mitochondrial aspartate/glutamate carriers.	SLC25A12 SLC25A13	1.70e-05	2	144	2	25410934
Pubmed	Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts.	HSPG2 MUC5AC	1.70e-05	2	144	2	23836919
Pubmed	c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration.	F3 MET	1.70e-05	2	144	2	19359592
Pubmed	Crystal structure and mutational analysis of a perlecan-binding fragment of nidogen-1.	HSPG2 NID1	1.70e-05	2	144	2	11427896
Pubmed	Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.	CSMD2 CSMD1	1.70e-05	2	144	2	24408017
Pubmed	Structural basis for the high-affinity interaction of nidogen-1 with immunoglobulin-like domain 3 of perlecan.	HSPG2 NID1	1.70e-05	2	144	2	11574465
Pubmed	Ca2+ Activation kinetics of the two aspartate-glutamate mitochondrial carriers, aralar and citrin: role in the heart malate-aspartate NADH shuttle.	SLC25A12 SLC25A13	1.70e-05	2	144	2	17213189
Pubmed	Sequence analysis and expression of a novel mouse homolog of Escherichia coli recA gene.	RAD51 RAD51D	1.70e-05	2	144	2	9655934
Pubmed	Trans-homophilic interaction of CADM1 promotes organ infiltration of T-cell lymphoma by adhesion to vascular endothelium.	CADM4 CADM1	1.70e-05	2	144	2	35213073
Pubmed	The ZGRF1 Helicase Promotes Recombinational Repair of Replication-Blocking DNA Damage in Human Cells.	RAD51 ZGRF1	1.70e-05	2	144	2	32640219
Pubmed	Gene for a tissue-specific transcriptional activator (EBF or Olf-1), expressed in early B lymphocytes, adipocytes, and olfactory neurons, is located on human chromosome 5, band q34, and proximal mouse chromosome 11.	EBF1 IL5	1.70e-05	2	144	2	8012110
Pubmed	Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain.	COL28A1 NID1	1.70e-05	2	144	2	16330543
Pubmed	Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.	TAF15 FUS	1.70e-05	2	144	2	9795213
Pubmed	A genetic association study of CSMD1 and CSMD2 with cognitive function.	CSMD2 CSMD1	1.70e-05	2	144	2	27890662
Pubmed	Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver.	SLC25A12 SLC25A13	1.70e-05	2	144	2	36967723
Pubmed	AGC1/2, the mitochondrial aspartate-glutamate carriers.	SLC25A12 SLC25A13	1.70e-05	2	144	2	27132995
Pubmed	Expression of the aspartate/glutamate mitochondrial carriers aralar1 and citrin during development and in adult rat tissues.	SLC25A12 SLC25A13	1.70e-05	2	144	2	12084073
Pubmed	The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.	CSMD2 CSMD1	1.70e-05	2	144	2	21439553
Pubmed	The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein.	SLC25A12 SLC25A13	1.70e-05	2	144	2	10369257
Pubmed	Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility.	C3 CSMD1	1.70e-05	2	144	2	31604923
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	IARS1 UGGT1 HNRNPM CKAP5 RECQL HEATR1 SRBD1 NDUFS2 ADD3 FXR1 SLC25A13 C3 LTF FUS EPB41L2 MOV10 KPNA2	1.89e-05	1257	144	17	36526897
Pubmed	Basement membranes in skin are differently affected by lack of nidogen 1 and 2.	HSPG2 LAMA4 NID1	1.93e-05	13	144	3	18356808
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	IARS1 HNRNPM CKAP5 FRYL SRBD1 FXR1 PRKAR1A TAF15 FUS MOV10 KPNA2	2.01e-05	551	144	11	34728620
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	HSPG2 ATP6V1B2 MAN2A1 CDHR2 DYNC2H1 SLC6A19 ADGRV1 SLC44A4 FABP1 TGM4 VPS13D NID1 CFAP70 UTRN SORL1	2.23e-05	1016	144	15	19056867
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	NRDC UGGT1 CKAP5 CPD MSI1 NDUFS2 FXR1 SLC25A13 CLUH HCFC1 EPB41L2	2.33e-05	560	144	11	35241646
Pubmed	Basement membrane composition in the early mouse embryo day 7.	HSPG2 LAMA4 NID1	3.05e-05	15	144	3	15895400
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYLK MYH7B GRK5 UGGT1 PPP1R9A HNRNPM FAM114A2 HEATR1 SRBD1 FER1L6 RYBP FXR1 MDN1 SLC25A12 SLC25A13 TAF15 FUS HSD17B4	3.05e-05	1442	144	18	35575683
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ATP6V1B2 RNGTT MYCBP2 UGGT1 PPP1R9A POLR2G CPD PPP6R1 CADM1 KIF15 LRP6 SSH2 HSD17B4 UTRN KPNA2	3.21e-05	1049	144	15	27880917
Pubmed	TRIM21 ameliorates hepatic glucose and lipid metabolic disorders in type 2 diabetes mellitus by ubiquitination of PEPCK1 and FASN.	MYCBP2 HNRNPM ADGRG4 LOXHD1 C3 NR5A1 FUS CFAP70 HSD17B4	3.27e-05	382	144	9	37249651
Pubmed	Replication of previous genome-wide association studies of bone mineral density in premenopausal American women.	CKAP5 ADGRV1 FER1L6 CSMD1	3.36e-05	44	144	4	20200978
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	ATP6V1B2 IARS1 HNRNPM RECQL HEATR1 MDN1 SLC25A13 FUS EPB41L2 KPNA2	3.62e-05	484	144	10	31995728
Pubmed	A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.	HNRNPM FXR1 TAF15 FUS	3.68e-05	45	144	4	25496916
Pubmed	HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.	KIAA0319L HNRNPM CKAP5	3.74e-05	16	144	3	24968937
Pubmed	Patterns of laminins and integrins in the embryonic ventricular zone of the CNS.	HSPG2 LAMA4 NID1	3.74e-05	16	144	3	17948866
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	RNGTT NRDC IARS1 UGGT1 POLR2G HNRNPM PPP6R1 NDUFS2 FXR1 SLC25A12 SLC25A13 PRKAR1A FUS HSD17B4 HCFC1 MOV10 KPNA2	4.03e-05	1335	144	17	29229926
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HSPG2 MAN2A1 MYCBP2 UGGT1 KIAA0319L LAMA4 RECQL CPD PPP6R1 MET CADM1 PGAP1 LRP6 NID1 TTC13 SORL1	4.04e-05	1201	144	16	35696571
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	IARS1 HNRNPM CKAP5 CPD ANKRD50 NDUFS2 SH3D19 SLC25A13 LRP6 HCFC1 EPB41L2 KPNA2	4.15e-05	708	144	12	39231216
Pubmed	Steroidogenic Factor-1 Lineage Origin of Skin Lesions in Carney Complex Syndrome.	MET PRKAR1A NR5A1	4.53e-05	17	144	3	35568059
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	IARS1 CKAP5 PPP6R1 MDN1 PRKAR1A FUS CLUH HCFC1 EPB41L2	4.58e-05	399	144	9	37536630
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	KPNA5 MYCBP2 DYNC2H1 UGGT1 PPP6R1 HEATR1 MSI1 NDUFS2 VPS13D MDN1 SLC25A12	4.75e-05	606	144	11	36538041
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	MYCBP2 RTN4IP1 CPD HEATR1 MSI1 ARMCX4 NDUFS2 VPS13D FXR1 MDN1 SLC25A12 SH3D19 SLC25A13 TTC13 HSD17B4 CLUH VPS13B MOV10	4.91e-05	1496	144	18	32877691
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ATP6V1B2 AFTPH MAN2A1 RNGTT PPP1R9A CKAP5 HEATR1 SRBD1 NDUFS2 MYEF2 MDN1 SLC25A13 PRKAR1A TMEM266 TAF15 UTRN EPB41L2 MOV10	4.96e-05	1497	144	18	31527615
Pubmed	G Protein-coupled receptor kinases phosphorylate LRP6 in the Wnt pathway.	GRK5 LRP6	5.09e-05	3	144	2	19801552
Pubmed	Identification of two new members of the CSMD gene family.	CSMD2 CSMD1	5.09e-05	3	144	2	12906867
Pubmed	Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals.	LRP6 USF1	5.09e-05	3	144	2	26034040
Pubmed	Coupling of mutated Met variants to DNA repair via Abl and Rad51.	RAD51 MET	5.09e-05	3	144	2	18632630
Pubmed	Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population.	VPS13D CSMD1	5.09e-05	3	144	2	20610895
Pubmed	The importance of XRCC2 in RAD51-related DNA damage repair.	RAD51 RAD51D	5.09e-05	3	144	2	20189471
Pubmed	The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response.	TAF15 FUS	5.09e-05	3	144	2	18620564
Pubmed	Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes.	FAT3 FAT2	5.09e-05	3	144	2	15744052
Pubmed	Probing the specificity of binding to the major nuclear localization sequence-binding site of importin-alpha using oriented peptide library screening.	KPNA5 KPNA2	5.09e-05	3	144	2	20406804
Pubmed	mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma.	TAF15 FUS	5.09e-05	3	144	2	21344536
Pubmed	The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development.	EBF3 EBF1	5.09e-05	3	144	2	9151732
Pubmed	Isolation of novel human and mouse genes of the recA/RAD51 recombination-repair gene family.	RAD51 RAD51D	5.09e-05	3	144	2	9512535
Pubmed	Interplay between human DNA repair proteins at a unique double-strand break in vivo.	RAD51 RAD51D	5.09e-05	3	144	2	16395335
Pubmed	Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis.	TAF15 FUS	5.09e-05	3	144	2	27311318
Pubmed	Lack of protein 4.1G causes altered expression and localization of the cell adhesion molecule nectin-like 4 in testis and can cause male infertility.	CADM4 EPB41L2	5.09e-05	3	144	2	21482674
Pubmed	Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity.	RAD51 RAD51D	5.09e-05	3	144	2	24088786
Pubmed	O-GlcNAc glycosylation stoichiometry of the FET protein family: only EWS is glycosylated with a high stoichiometry.	TAF15 FUS	5.09e-05	3	144	2	27903134
Pubmed	Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.	TAF15 FUS	5.09e-05	3	144	2	27460707
Pubmed	Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis.	NR5A1 USF1	5.09e-05	3	144	2	18165439
Pubmed	Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions.	TAF15 FUS	5.09e-05	3	144	2	23049996
Pubmed	circZNF532 promotes endothelial-to-mesenchymal transition in diabetic retinopathy by recruiting TAF15 to stabilize PIK3CD.	ZNF532 TAF15	5.09e-05	3	144	2	38811189
Pubmed	The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP.	HCFC1 GABPB1	5.09e-05	3	144	2	10675337
Pubmed	A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins.	TAF15 FUS	5.09e-05	3	144	2	23975937
Pubmed	Transcriptional Regulation Factors of the Human Mitochondrial Aspartate/Glutamate Carrier Gene, Isoform 2 (SLC25A13): USF1 as Basal Factor and FOXA2 as Activator in Liver Cells.	SLC25A13 USF1	5.09e-05	3	144	2	30995827
Pubmed	Cloning of a cDNA encoding a novel importin-alpha homologue, Qip1: discrimination of Qip1 and Rch1 from hSrp1 by their ability to interact with DNA helicase Q1/RecQL.	RECQL KPNA2	5.09e-05	3	144	2	9168958
Pubmed	FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.	TAF15 FUS	5.09e-05	3	144	2	21856723
Pubmed	Role of FET proteins in neurodegenerative disorders.	TAF15 FUS	5.09e-05	3	144	2	27415968
Interaction	SIRT7 interactions	MYCBP2 UGGT1 CKAP5 RECQL FRYL HEATR1 MYEF2 FXR1 MDN1 SLC25A13 TAF15 LTF FUS UTRN CLUH HCFC1 EPB41L2 MOV10	4.15e-06	744	140	18	int:SIRT7
Interaction	MIR29B2 interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	9.98e-06	71	140	6	int:MIR29B2
Interaction	MIR20A interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	1.27e-05	74	140	6	int:MIR20A
Interaction	LGALS9 interactions	ATP6V1B2 IARS1 KIAA0319L HNRNPM LAMA4 RECQL HEATR1 MET MDN1 SLC25A13 NID1 FUS EPB41L2 SORL1 KPNA2	1.50e-05	588	140	15	int:LGALS9
Interaction	GUCY1B1 interactions	MYCBP2 NOX5 CADM1 GUCY1B1 EPB41L2	1.83e-05	47	140	5	int:GUCY1B1
Interaction	GSK3A interactions	AFTPH HNRNPM PPP6R1 SRBD1 ADD3 VPS13D FXR1 MDN1 PRKAR1A LRP6 LTF UTRN KPNA2	2.18e-05	464	140	13	int:GSK3A
Interaction	MIR29C interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	3.65e-05	89	140	6	int:MIR29C
Interaction	MYCBP2 interactions	RAD51 MYCBP2 PPP1R9A ATP13A2 MYEF2 FXR1 MDN1 GUCY1B1 TAF15 FUS SSH2	3.89e-05	355	140	11	int:MYCBP2
Interaction	MIR221 interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	3.89e-05	90	140	6	int:MIR221
Interaction	MDK interactions	PPIG FXR1 LRP6 NID1 CLUH SORL1	4.14e-05	91	140	6	int:MDK
Interaction	MIR19B2 interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	4.98e-05	94	140	6	int:MIR19B2
Interaction	MIRLET7F1 interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	4.98e-05	94	140	6	int:MIRLET7F1
Interaction	CCDC8 interactions	ATP6V1B2 MYCBP2 IARS1 UGGT1 PPP1R9A CKAP5 HEATR1 FXR1 MDN1 SLC25A13 PRKAR1A HSD17B4 UTRN EPB41L2 KPNA2	5.29e-05	656	140	15	int:CCDC8
Interaction	MIR128-2 interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	6.66e-05	99	140	6	int:MIR128-2
Interaction	MIRLET7D interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	7.44e-05	101	140	6	int:MIRLET7D
Interaction	MIRLET7A3 interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	7.86e-05	102	140	6	int:MIRLET7A3
Interaction	MIR34B interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	1.20e-04	110	140	6	int:MIR34B
Interaction	LOXL2 interactions	IARS1 UGGT1 HNRNPM FXR1 SLC25A12 SLC25A13 A2ML1 C3 LTF HSD17B4 GOT2	1.40e-04	410	140	11	int:LOXL2
Interaction	FBXO2 interactions	HSPG2 CDHR2 CADM4 KIAA0319L LAMA4 CPD ADGRV1 MET NID1 TTC13 SORL1	1.43e-04	411	140	11	int:FBXO2
Interaction	MIRLET7I interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	1.46e-04	114	140	6	int:MIRLET7I
Interaction	MIR18A interactions	IARS1 HNRNPM MSI1 TAF15 FUS	1.55e-04	73	140	5	int:MIR18A
Interaction	MIR29B1 interactions	HNRNPM MSI1 MYEF2 TAF15 FUS	1.55e-04	73	140	5	int:MIR29B1
Interaction	MIRLET7G interactions	IARS1 HNRNPM MSI1 MYEF2 TAF15 FUS	1.68e-04	117	140	6	int:MIRLET7G
Interaction	MIR15A interactions	IARS1 HNRNPM MYEF2 TAF15 FUS	1.76e-04	75	140	5	int:MIR15A
GeneFamily	Cadherin related	DCHS2 CDHR2 CDHR3 FAT3 FAT2	3.04e-08	17	102	5	24
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	RYBP TAF15 FUS	2.15e-04	21	102	3	89
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	A2ML1 C3	1.11e-03	9	102	2	1234
GeneFamily	UPF1 like RNA helicases	ZGRF1 MOV10	1.68e-03	11	102	2	1169
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	KPNA5 ARMCX4 KPNA2	1.83e-03	43	102	3	409
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 MYLK COL6A6 GRK5 LAMA4 EBF1 ADGRG4 NID1 C3 EPB41L2	1.10e-09	200	144	10	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	FMO2 DYNC2H1 GRK5 EBF1 SH3D19 SLC25A13 NID1 C3 SSH2	1.23e-08	190	144	9	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	FMO2 DYNC2H1 GRK5 EBF1 SLC25A13 NID1 C3 SSH2 EPB41L2	1.29e-08	191	144	9	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FMO2 MYLK COL6A6 FAT3 GRK5 LAMA4 EBF1 SH3D19 NID1	1.61e-08	196	144	9	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NWD1 DYNC2H1 CDHR3 SLC44A4 DNAI4 CFAP70 MUC5AC IQUB	1.12e-07	176	144	8	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ELAPOR2 ACADL PPP1R9A ADGRV1 F3 MET CADM1 HSD17B4	1.78e-07	187	144	8	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 PGAP1 NID1	1.78e-07	187	144	8	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ELAPOR2 FMO2 SLC26A5 ADGRV1 F3 CADM1 C3 UTRN	1.78e-07	187	144	8	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GRK5 LAMA4 EBF1 LOXHD1 NID1 PLCXD3 EPB41L2	2.01e-07	190	144	8	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GRK5 LAMA4 EBF1 LOXHD1 NID1 PLCXD3 EPB41L2	2.01e-07	190	144	8	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GRK5 LAMA4 EBF1 LOXHD1 NID1 PLCXD3 EPB41L2	2.09e-07	191	144	8	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 PGAP1 NID1	2.09e-07	191	144	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 PGAP1 NID1	2.18e-07	192	144	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	MAN2A1 CKAP5 CPD FRYL ADGRV1 ANKRD50 UTRN VPS13B	2.27e-07	193	144	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	facs-Liver-Non-hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 LAMA4 ARMCX4 ADD3 NID1 FUS GARRE1 EPB41L2	2.27e-07	193	144	8	8084fa0ce61f1f4a728423b6b81df04eaa5af5b6
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FMO2 MYLK FAT3 GRK5 LAMA4 SH3D19 PGAP1 NID1	2.36e-07	194	144	8	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FMO2 DYNC2H1 GRK5 EBF1 NID1 C3 SSH2 EPB41L2	2.45e-07	195	144	8	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	FMO2 MYLK COL6A6 FAT3 LAMA4 EBF1 SH3D19 NID1	2.45e-07	195	144	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 MYLK COL6A6 FAT3 LAMA4 EBF1 SH3D19 NID1	2.55e-07	196	144	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FMO2 MYLK COL6A6 FAT3 LAMA4 EBF1 SH3D19 NID1	2.75e-07	198	144	8	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ELAPOR2 ACADL PPP1R9A ADGRV1 MET CADM1 LRP6 C3	2.86e-07	199	144	8	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1 EPB41L2	2.97e-07	200	144	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1 EPB41L2	2.97e-07	200	144	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 MYLK COL6A6 FAT3 LAMA4 EBF1 NID1 EPB41L2	2.97e-07	200	144	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 MYLK COL6A6 FAT3 LAMA4 EBF1 NID1 EPB41L2	2.97e-07	200	144	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	ASK440-Epithelial\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	FMO2 CDHR3 SLC44A4 F3 MET CADM1 C3 CFAP70	2.97e-07	200	144	8	cb617e2a0ca82b470b473b8d5906bc8879c85718
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1 EPB41L2	2.97e-07	200	144	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ELAPOR2 FRMPD4 CDHR2 FAT3 TOP6BL ADGRV1 ADAM2	1.00e-06	162	144	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT3 SLC44A4 FSIP2 MET C3 LTF MUC5AC	1.18e-06	166	144	7	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT3 SLC44A4 FSIP2 MET C3 LTF MUC5AC	1.18e-06	166	144	7	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT3 SLC44A4 FSIP2 MET C3 LTF MUC5AC	1.18e-06	166	144	7	4586d6725403f879fc96f67be579022587ce1906
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PPP1R9A MET NXF3 C3 LTF CTSE MUC5AC	1.33e-06	169	144	7	a54a8494c1feff29d77ab4737fcfabc84ace5c94
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EBF3 LAMA4 EBF1 F3 ADGRG4 PLCXD3 EPB41L2	1.68e-06	175	144	7	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	FMO2 COL6A6 GRK5 EBF1 SH3D19 PGAP1 NID1	1.95e-06	179	144	7	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GRK5 LAMA4 EBF1 ADGRG4 NID1 PLCXD3 EPB41L2	2.34e-06	184	144	7	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 F3 FABP1 NID1 C3 PLCXD3 AADAT	2.42e-06	185	144	7	eaa54b76743628c89b4310be57b87fa92b75fd37
ToppCell	facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 F3 FABP1 NID1 C3 PLCXD3 AADAT	2.42e-06	185	144	7	f7f4c921d248c637351e2e882589b99ba7f04b66
ToppCell	facs-Thymus-Epithelium-24m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 F3 FABP1 NID1 C3 PLCXD3 AADAT	2.42e-06	185	144	7	ff38a15af3dec36d9993f06623591872b5d1da9a
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL6A6 GRK5 TOP6BL EBF1 PGAP1 NID1 C3	2.60e-06	187	144	7	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MYLK GRK5 LAMA4 GUCY1B1 SH3D19 PGAP1 EPB41L2	2.60e-06	187	144	7	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GRK5 LAMA4 EBF1 NID1 PLCXD3 EPB41L2	2.79e-06	189	144	7	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	ELAPOR2 PPP1R9A ADGRV1 F3 MET CADM1 C3	2.79e-06	189	144	7	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GRK5 LAMA4 EBF1 NID1 PLCXD3 EPB41L2	2.79e-06	189	144	7	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	FMO2 MYLK COL6A6 FAT3 LAMA4 EBF1 NID1	2.89e-06	190	144	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	PPP1R9A ADGRV1 SLC44A4 FER1L6 MET LTF MUC5AC	2.89e-06	190	144	7	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GRK5 LAMA4 EBF1 NID1 PLCXD3 EPB41L2	2.99e-06	191	144	7	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYLK COL6A6 GRK5 LAMA4 SH3D19 PGAP1 EPB41L2	2.99e-06	191	144	7	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	(7)_Epithelial-E_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ELAPOR2 MYH7B ADGRV1 MET CADM1 C3 CTSE	2.99e-06	191	144	7	0fc8d109d5c50957ceef5b8b8b818b0c598b1bbe
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FMO2 GRK5 EBF1 SH3D19 SLC25A13 NID1 SSH2	2.99e-06	191	144	7	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYLK COL6A6 GRK5 LAMA4 SH3D19 PGAP1 EPB41L2	2.99e-06	191	144	7	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ELAPOR2 ACADL PPP1R9A ADGRV1 MET CADM1 LRP6	2.99e-06	191	144	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GRK5 LAMA4 EBF1 NID1 PLCXD3 EPB41L2	2.99e-06	191	144	7	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GRK5 LAMA4 EBF1 LOXHD1 NID1 EPB41L2	3.10e-06	192	144	7	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 GRK5 LAMA4 EBF1 LOXHD1 NID1 EPB41L2	3.10e-06	192	144	7	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	FMO2 DYNC2H1 GRK5 EBF1 NID1 C3 EPB41L2	3.10e-06	192	144	7	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ACADL PPP1R9A KIAA0319L ADGRV1 F3 CADM1 CTSE	3.10e-06	192	144	7	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK GRK5 LAMA4 EBF1 LOXHD1 NID1 EPB41L2	3.21e-06	193	144	7	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FMO2 MYLK FAT3 GRK5 LAMA4 SH3D19 NID1	3.21e-06	193	144	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FMO2 MYLK FAT3 GRK5 LAMA4 SH3D19 NID1	3.21e-06	193	144	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	FMO2 DYNC2H1 GRK5 EBF1 PGAP1 NID1 C3	3.21e-06	193	144	7	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	FMO2 GRK5 EBF1 SH3D19 NID1 C3 SSH2	3.32e-06	194	144	7	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	GRK5 EBF1 ADD3 SH3D19 SLC25A13 NID1 SSH2	3.32e-06	194	144	7	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIAA0319L CPD SLC44A4 C3 LTF MUC5AC SORL1	3.43e-06	195	144	7	2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK GRK5 LAMA4 EBF1 LOXHD1 NID1 EPB41L2	3.43e-06	195	144	7	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NWD1 DYNC2H1 CDHR3 SLC44A4 DNAI4 CFAP70 IQUB	3.43e-06	195	144	7	0e763f36786515698b593e5c93f6a56619c1242d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 EBF1 ADGRG4 SH3D19 NID1 C3 EPB41L2	3.43e-06	195	144	7	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	FMO2 DYNC2H1 GRK5 EBF1 NID1 C3 EPB41L2	3.43e-06	195	144	7	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FMO2 LAMA4 EBF1 LOXHD1 NID1 PLCXD3 EPB41L2	3.43e-06	195	144	7	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NWD1 DYNC2H1 CDHR3 SLC44A4 DNAI4 CFAP70 IQUB	3.43e-06	195	144	7	581b04220587e1d5198b1abd6965965ace7803e7
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	GRK5 TOP6BL EBF1 ADD3 SLC25A13 NID1 C3	3.43e-06	195	144	7	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1	3.43e-06	195	144	7	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIAA0319L CPD SLC44A4 C3 LTF MUC5AC SORL1	3.43e-06	195	144	7	576142b4e75457c0973051bccc4163bd624496af
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NWD1 DYNC2H1 CDHR3 SLC44A4 DNAI4 CFAP70 IQUB	3.43e-06	195	144	7	93b1559382a12cfb158aa5fac7386e38b4f87989
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1	3.43e-06	195	144	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1	3.43e-06	195	144	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1	3.43e-06	195	144	7	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIAA0319L CPD SLC44A4 C3 LTF MUC5AC SORL1	3.43e-06	195	144	7	8f151066ad3ebd9661ea0b733f03c2ce1518f9ad
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FMO2 LAMA4 EBF1 LOXHD1 NID1 PLCXD3 EPB41L2	3.43e-06	195	144	7	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NWD1 DYNC2H1 CDHR3 RFX2 DNAI4 CFAP70 IQUB	3.43e-06	195	144	7	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NWD1 DYNC2H1 CDHR3 RFX2 DNAI4 CFAP70 IQUB	3.43e-06	195	144	7	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NWD1 DYNC2H1 CDHR3 SLC44A4 DNAI4 CFAP70 MUC5AC	3.43e-06	195	144	7	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK GRK5 LAMA4 EBF1 LOXHD1 NID1 EPB41L2	3.43e-06	195	144	7	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK FAT3 GRK5 LAMA4 EBF1 NID1 EPB41L2	3.55e-06	196	144	7	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|COVID-19 / Condition, Lineage and Cell class	FMO2 SLC44A4 F3 FER1L6 MET C3 MUC5AC	3.55e-06	196	144	7	dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAT3 PPP1R9A TOP6BL MET CADM1 FHIT SORL1	3.55e-06	196	144	7	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NUP210L COL28A1 TATDN3 SLC41A3 A2ML1 TMEM266 DNAI4	3.55e-06	196	144	7	efeb272bc9e37e60d15d056b7574991c5c7501bc
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIAA0319L CPD MET C3 LTF MUC5AC SORL1	3.55e-06	196	144	7	8e909c31733762646359fe78b645cbd60237459e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK GRK5 LAMA4 EBF1 NID1 PLCXD3 EPB41L2	3.55e-06	196	144	7	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1	3.55e-06	196	144	7	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK FAT3 GRK5 LAMA4 EBF1 NID1 EPB41L2	3.55e-06	196	144	7	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1	3.55e-06	196	144	7	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|Epithelial / Condition, Lineage and Cell class	FMO2 F3 FER1L6 FAT2 C3 MUC5AC SORL1	3.67e-06	197	144	7	78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GRK5 LAMA4 EBF1 LOXHD1 NID1 PLCXD3 EPB41L2	3.67e-06	197	144	7	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NWD1 DYNC2H1 CDHR3 RFX2 DNAI4 CFAP70 IQUB	3.67e-06	197	144	7	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ELAPOR2 FMO2 SLC26A5 ADGRV1 SLC44A4 C3 UTRN	3.67e-06	197	144	7	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMO2 MYLK COL6A6 FAT3 LAMA4 SH3D19 NID1	3.67e-06	197	144	7	13896ec65ccda0b928c91d41112dc01b480036b7
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NWD1 DYNC2H1 CDHR3 RFX2 DNAI4 CFAP70 IQUB	3.80e-06	198	144	7	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	EBF3 GRK5 LAMA4 EBF1 NID1 PLCXD3 EPB41L2	3.80e-06	198	144	7	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ACADL PPP1R9A ADGRV1 MET CADM1 LRP6 FHIT	3.92e-06	199	144	7	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Biopsy_Other_PF-Epithelial-AT2\|Biopsy_Other_PF / Sample group, Lineage and Cell type	ELAPOR2 ACADL PPP1R9A F3 MET CADM1 C3	3.92e-06	199	144	7	9a65acfe9bf500db72142469cf17bf0973540001
Drug	Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	KPNA5 GRK5 PPP1R9A KIAA0319L RECQL GUCY1B1 NID1 TAF15 GABPB1	4.37e-06	198	142	9	7261_UP
Drug	5-aza-2′-deoxycytidine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	DYNC2H1 KIAA0319L FRYL ADD3 CADM1 SLC41A3 PGAP1 LRP6 VPS13B	4.56e-06	199	142	9	920_DN
Disease	common bile duct disease (implicated_via_orthology)	SLC25A12 SLC25A13	2.20e-05	2	139	2	DOID:4137 (implicated_via_orthology)
Disease	Nonsyndromic Deafness	SLC26A5 ADGRV1 SLC44A4 MET LOXHD1	4.15e-05	81	139	5	C3711374
Disease	citrullinemia (implicated_via_orthology)	SLC25A12 SLC25A13	6.59e-05	3	139	2	DOID:9273 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis type 6 (implicated_via_orthology)	TAF15 FUS	6.59e-05	3	139	2	DOID:0060198 (implicated_via_orthology)
Disease	intrahepatic cholestasis (implicated_via_orthology)	SLC25A12 SLC25A13	1.31e-04	4	139	2	DOID:1852 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	RAD51 KPNA5 MICAL1 DYNC2H1 RECQL MSI1 RFX2 PKDREJ F3 FXR1 CADM1 ZNF532 FUS VPS13B SORL1	1.72e-04	1074	139	15	C0006142
Disease	sarcoma (is_marker_for)	MET FUS	2.18e-04	5	139	2	DOID:1115 (is_marker_for)
Disease	lumbar disc degeneration	DYNC2H1 MYH7B CSMD1	3.07e-04	28	139	3	EFO_0004994
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	ATP13A2 TAF15 FUS	3.78e-04	30	139	3	DOID:332 (implicated_via_orthology)
Disease	pancreatic cancer (biomarker_via_orthology)	RAD51 MET	4.56e-04	7	139	2	DOID:1793 (biomarker_via_orthology)
Disease	coronary aneurysm	GRK5 CSMD2 CSMD1	6.00e-04	35	139	3	EFO_1000881
Disease	response to darapladib, cardiovascular event measurement	ANKRD50 FHIT	6.06e-04	8	139	2	EFO_0006919, EFO_0008395
Disease	hypertension (biomarker_via_orthology)	HSPG2 GRK5 SLC6A19 F3 C3 HSD17B4	7.44e-04	227	139	6	DOID:10763 (biomarker_via_orthology)
Disease	allergic rhinitis (biomarker_via_orthology)	MUC5AC IL5	9.67e-04	10	139	2	DOID:4481 (biomarker_via_orthology)
Disease	microfibrillar-associated protein 2 measurement	ATP13A2 A2ML1	1.18e-03	11	139	2	EFO_0801801
Disease	hearing impairment	SLC26A5 ADGRV1 LOXHD1 HSD17B4	1.21e-03	98	139	4	C1384666
Disease	neuritic plaque measurement	EBF3 DYNC2H1 NDUFS2 CSMD1 FHIT IQUB GOT2	1.37e-03	349	139	7	EFO_0006798
Disease	frontotemporal dementia (implicated_via_orthology)	TAF15 FUS	1.41e-03	12	139	2	DOID:9255 (implicated_via_orthology)
Disease	tyrosine-protein kinase ZAP-70 measurement	C3 PLCXD3	1.41e-03	12	139	2	EFO_0020833
Disease	rhinitis (biomarker_via_orthology)	C3 MUC5AC	1.66e-03	13	139	2	DOID:4483 (biomarker_via_orthology)
Disease	cognitive inhibition measurement	OR13C9 A2ML1 OR13C2	1.71e-03	50	139	3	EFO_0007969
Disease	hepatocellular carcinoma (biomarker_via_orthology)	PPP1R9A MET CADM1 C3	1.73e-03	108	139	4	DOID:684 (biomarker_via_orthology)
Disease	wet macular degeneration	SLC44A4 C3	1.93e-03	14	139	2	EFO_0004683
Disease	sickle cell anemia (is_marker_for)	F3 C3	1.93e-03	14	139	2	DOID:10923 (is_marker_for)
Disease	early cardiac repolarization measurement	KPNA5 MYCBP2	1.93e-03	14	139	2	EFO_0004885
Disease	eating disorder, bipolar disorder	FXR1 AIM2	1.93e-03	14	139	2	EFO_0005203, MONDO_0004985
Disease	Hereditary Breast and Ovarian Cancer Syndrome	RAD51 RAD51D	1.93e-03	14	139	2	C0677776
Disease	Beta blocking agent use measurement	RYBP MET CLCN6 GUCY1B1	2.11e-03	114	139	4	EFO_0009929
Disease	Lymphoma, Follicular, Grade 2	ATP6V1B2 EBF1	2.22e-03	15	139	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	ATP6V1B2 EBF1	2.22e-03	15	139	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	ATP6V1B2 EBF1	2.22e-03	15	139	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	ATP6V1B2 EBF1	2.22e-03	15	139	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	ATP6V1B2 EBF1	2.22e-03	15	139	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	ATP6V1B2 EBF1	2.22e-03	15	139	2	C0079758
Disease	serum urea measurement	EBF1 TMEM266 DNAI4 PLCXD3 SORL1	2.36e-03	195	139	5	EFO_0009795
Disease	diastolic blood pressure, alcohol drinking	EBF1 CLCN6 GUCY1B1 MOV10	2.39e-03	118	139	4	EFO_0004329, EFO_0006336
Disease	response to triptolide, cytotoxicity measurement	ZNF532 CSMD1	2.53e-03	16	139	2	EFO_0006952, EFO_0007662
Disease	sugar consumption measurement	UGGT1 PRKAR1A CSMD1 VPS13B	2.54e-03	120	139	4	EFO_0010158
Disease	caudal anterior cingulate cortex volume measurement	FAT2 FHIT	2.86e-03	17	139	2	EFO_0010289
Disease	migraine disorder, type 2 diabetes mellitus	FRYL EBF1 DNAI4	2.88e-03	60	139	3	MONDO_0005148, MONDO_0005277
Disease	methadone dose measurement	GRK5 FHIT UTRN	3.16e-03	62	139	3	EFO_0007907
Disease	tuberculosis	FRMPD4 DYNC2H1 LAMA4 CSMD1 VPS13B	3.65e-03	216	139	5	MONDO_0018076
Disease	comparative body size at age 10, self-reported	EBF1 RYBP CADM1 PRKAR1A CSMD1 FHIT MOV10	3.85e-03	420	139	7	EFO_0009819
Disease	sphingomyelin 22:0 measurement	HEATR1 CSMD1	3.96e-03	20	139	2	EFO_0010395
Disease	pars triangularis volume measurement	FHIT EPB41L2	3.96e-03	20	139	2	EFO_0010321
Disease	Lymphoma, Follicular	ATP6V1B2 EBF1	3.96e-03	20	139	2	C0024301
Disease	IgA glomerulonephritis (is_marker_for)	FABP1 C3	3.96e-03	20	139	2	DOID:2986 (is_marker_for)
Disease	osteoarthritis	MYLK SRBD1 GUCY1B1 SLC25A13 FHIT	4.10e-03	222	139	5	MONDO_0005178
Disease	renal cell carcinoma (is_implicated_in)	MET LTF FHIT	4.27e-03	69	139	3	DOID:4450 (is_implicated_in)
Disease	COVID-19 (is_implicated_in)	F3 C3	4.36e-03	21	139	2	DOID:0080600 (is_implicated_in)
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	GRK5 CKAP5	4.36e-03	21	139	2	EFO_0004286, EFO_0004792

Protein segments in the cluster

Peptide	Gene	Start	Entry
AVITVENGKTIQFGE	AADAT	51	Q8N5Z0
EGSGIQIQVISFATE	CSMD1	1836	Q96PZ7
GAGIQIQVVSFVTEQ	CSMD2	1831	Q7Z408
QQIDTVFGEKSVITL	CCDC62	381	Q6P9F0
NGSLSDVVIVVAVTN	ACADL	206	P28330
SETTQTEINGAIVFG	ADGRG4	806	Q8IZF6
KVNIIGEVVDQGSTN	ADD3	191	Q9UEY8
SDTTVVAQKVFQLIG	ADAM2	196	Q99965
EISIVTNRGFSVEKQ	AFTPH	301	Q6ULP2
GTIVNGLFVVQKVTE	AIM2	261	O14862
QINIVATVVEEGTGV	A2ML1	311	A8K2U0
TVVFGDQEFSKNITI	ADGRV1	946	Q8WXG9
VVRVQEGETANFTVL	ADGRV1	1011	Q8WXG9
TFEIGQTSANITVEI	ADGRV1	1921	Q8WXG9
VTVQATFGTQVVEKV	C3	106	P01024
TVLSIASAQGNVEVV	ANKRD50	816	Q9ULJ7
GSVQVQVVASFQGEV	ARMCX4	946	Q5H9R4
VGNIVTGDDIQTQVI	KPNA5	321	O15131
VETAVFGTENNLIIT	NWD1	1131	Q149M9
QQVTGSSGTVKVVVV	RAD51D	191	O75771
STDQVGEFFKQIGII	TAF15	246	Q92804
LGTAQKQVEVIVDTG	HSPG2	3191	P98160
ADEFGVAVVITNQVV	RAD51	256	Q06609
VTQQFKTIAGEDGEI	NOX5	31	Q96PH1
QAQVVTTVVGGVTKT	HCFC1	646	P51610
VFKEVEGQSQGSVLA	NXF3	456	Q9H4D5
QVTVELTVEGSFAKQ	MYLK	116	Q15746
VEGLDQFTGEVISSV	MDN1	4081	Q9NU22
FVVGAVEQVVTSAAE	KIF15	196	Q9NS87
IFLEGVTVKGVTQVT	RNGTT	231	O60942
GIEGQSVEVSNIVDI	MAN2A1	856	Q16706
TDTIGQQATAQVTVI	KIAA0319L	576	Q8IZA0
VFVGTKESIGNVQVL	FXR1	336	P51114
TIFVQGLGENVTIES	FUS	286	P35637
VVTAESVDGAIQQVV	GABPB1	251	Q06547
IGTVTFEQSIEAVQA	HNRNPM	246	P52272
VEVTNTSTGVATIFN	LOXHD1	2031	Q8IVV2
DQVSVEGLTVVGQQF	CTSE	151	P14091
VGQVAATVENRFTKT	DDX60L	801	Q5H9U9
SVGSSNQIVQEIVET	FSIP2	2981	Q5CZC0
TQAGASVITVETVIQ	EPB41L2	801	O43491
SVITVETVIQENVGA	EPB41L2	806	O43491
VTKGQSVEQVVFAVG	MYH7B	456	A7E2Y1
DVVSLVSVNIQVGDV	FAT2	2776	Q9NYQ8
ITGGEFTRQAEVTFV	NID1	511	P14543
TIQRKFGEITNEAVS	FRYL	2716	O94915
KAQEDGSQGFTVVVS	LRP6	991	O75581
TANFVNGRTVEETQV	MICAL1	241	Q8TDZ2
IAGQVQVDGESVQIT	GUCY1B1	506	Q02153
GAQTVVVIKASGEVF	MUC5AC	496	P98088
NELVTFVDIGVVVAS	OR10G3	196	Q8NGC4
IGAVNSAVQSVFVVQ	OR13C2	151	Q8NGS9
IFVGGLSVNTTVEDV	MSI1	111	O43347
TNNITDFTVKEIVAG	ELAPOR2	731	A8MWY0
VGVQVAEAEKVNTTA	MAGEA13P	26	A6NCF6
DVVAIIGTQDIVFGE	NDUFS2	446	O75306
TKFAIDQNTGVVVLV	DCHS2	2391	Q6V1P9
FGQVISGQEVVREIE	PPIG	141	Q13427
VTGTDEQTQVVIDAG	KPNA2	321	P52292
EIKQTFSINEVTGEI	PCDHB4	286	Q9Y5E5
TGDGQNLFTKDVTVI	CADM1	41	Q9BY67
GKEVEVNSNSGIFIT	DYNC2H1	1776	Q8NCM8
QLFTVQVQTEAIGEG	ATP13A2	101	Q9NQ11
TGEVVSGVVSKVFNQ	CKAP5	86	Q14008
GTKVNVTITVEDIND	CDHR2	676	Q9BYE9
TQLKFGVVQTSVEEC	CLCN6	106	P51797
ADLFQTTQRVGTVVE	FHIT	56	P49789
QTFSQTTKIVGEEVV	IGSF22	26	Q8N9C0
EIFQGIGTLESQTVQ	IL5	66	P05113
NASDTNVEIFVIGVV	COL28A1	921	Q2UY09
VGFVIVTFQEQGETE	CACNA1S	1061	Q13698
VGVTDLQVLTVQVTD	CDHR3	111	Q6ZTQ4
EFNQVVLGDSAKITV	CFAP70	36	Q5T0N1
SEEVIINGQVSETVK	FRMPD4	181	Q14CM0
FQTKVQETGDIVISN	HSD17B4	586	P51659
EKTGNDLGVTVQVTI	CD300LF	111	Q8TDQ1
FGQAGLVVVDTAQIE	GARRE1	416	O15063
ESGQQLFSVVTLKVF	FAT3	911	Q8TDW7
TDGTNVAVTQVFIKV	FAT3	1436	Q8TDW7
VTVKSEGAIQVNFTL	CPD	856	O75976
EVQTENVTVAEGGVA	CADM4	26	Q8NFZ8
FQVVVSTTVNVDGHV	EBF1	211	Q9UH73
ATVGQGISNVIEKAE	FAM114A2	101	Q9NRY5
DGLTDVSQIITVTVQ	IQUB	216	Q8NA54
IKTTQVFDINGTDVT	DNAI4	111	Q5VTH9
GTVEENIDVIIFATG	FMO2	316	Q99518
VSFIAGETVIQQGDE	PRKAR1A	156	P10644
TVGKNEFSQTVGEVF	SLC44A4	126	Q53GD3
TVSSVFKGISVNAEQ	HEATR1	1146	Q9H583
FQVVVSTTVNVDGHV	EBF3	211	Q9H4W6
VFIAQVGQDLVSQTE	GRK5	116	P34947
VDVVVGFDVSTQEKG	COL6A6	1186	A6NMZ7
VGTETQVSVAFQVTN	COL6A6	1231	A6NMZ7
IQTVNEDTGKVIVFS	NUP210L	1146	Q5VU65
IVKVNNGIRDFSTSV	LAMA4	1706	Q16363
AGIVNSAVQTTFVVQ	OR13C9	151	Q8NGT0
IGNQVFSGKTIFTEE	FER1L6	1501	Q2WGJ9
TDIGEVSQFLTEGII	MET	1116	P08581
KQGTLSEFVVVSGNE	RTN4IP1	151	Q8WWV3
VLEVSGSKAVVQVFE	ATP6V1B2	86	P21281
SNIVTVGDVEEINKT	UTRN	2251	P46939
VTQFNKVAGAVVSSV	RGL2	291	O15211
KDSVIVSIINGFTSV	SLC6A19	301	Q695T7
TGQEVIINSGLETVE	SORL1	821	Q92673
VTGQEVELTTVATQA	NR5A1	326	Q13285
KGISVEEVIEVTTQN	TATDN3	246	Q17R31
VAFVKDVTVLQNTDG	LTF	561	P02788
RIKVFEGQTNIETSG	SH3D19	16	Q5HYK7
VKVNGILSTEIFGVE	TOP6BL	146	Q8N6T0
KVVGVQEDGSVVDVS	TMEM132B	446	Q14DG7
GTVTFEQAIEAVQAI	MYEF2	276	Q9P2K5
KVGSVEEFQGQERSV	MOV10	861	Q9HCE1
VIQTKVGVVSAFAQT	RFX2	496	P48378
FTQVNFIDSVGVKTL	SLC26A5	646	P58743
ISVIFEVSQLGVVNT	PKDREJ	1931	Q9NTG1
VTVGNVTVIITDFKE	RYBP	161	Q8N488
VEGQSVINSQTFVVL	SLC41A3	396	Q96GZ6
QIGIVKVNGTITFID	MYCBP2	2491	O75592
EVTVKTSFSQILGQV	PGAP1	576	Q75T13
ATLQNESGKEVTVAV	TGM4	91	P49221
SEELEQFQKTGTIVV	IARS1	921	P41252
QFQKTGTIVVEGHEL	IARS1	926	P41252
TITAGSKVIQNEFTV	FABP1	51	P07148
TVVQLEGDNKLVTTF	FABP1	81	P07148
QIQGVAVTSSADVEV	SRBD1	786	Q8N5C6
ENSEVLKSGRFVTVQ	GOT2	116	P00505
VTFENVKEIFGQTII	SLC25A12	106	O75746
EVTFEDVKQVFGQTT	SLC25A13	106	Q9UJS0
TGQEVIVIQDTGFSV	CLUH	36	O75153
SANEIQVVVATVAFG	RECQL	361	P46063
ETVQNFVSVFGTVAK	PLCXD3	56	Q63HM9
GFAEKVVEGISVSVN	UHRF1BP1L	116	A0JNW5
SVVVFKITGVNGEID	UHRF1BP1L	1191	A0JNW5
SSDVGVSVIVKNVRN	ZNF532	56	Q9HCE3
GDKVGNILFSVETQT	TTC13	696	Q8NBP0
DAVVTQVNKVGLFTE	POLR2G	86	P62487
EIVTEIESISQGVGQ	SSH2	751	Q76I76
QNSVVFGTSAQEVVK	POLK	281	Q9UBT6
FVEGLVQGNVTSTES	NRDC	856	O43847
SQVAGTTEVVENLVT	TEX11	21	Q8IYF3
GQQGTITLDDVKFVT	PPP1R36	111	Q96LQ0
QSFEQVGTKVNVTVE	F3	146	P13726
FEGEQSQSVIVSGIQ	PPP6R1	256	Q9UPN7
QGTVTFEDVAVKFTQ	ZNF552	11	Q9H707
IDINSQGTQVVFLTG	VPS13B	3331	Q7Z7G8
KTVQVSTVDAFQGAE	ZGRF1	1986	Q86YA3
GIVIKIEVQTNDEGS	ZNF777	366	Q9ULD5
IEGGISEVEIISQQV	TMEM266	16	Q2M3C6
TQVKGTEVNTTVIGE	UGGT1	261	Q9NYU2
EFIQSSGKNGVVVFS	UGT2A2	301	P0DTE5
KTAETEEGTVQIQEG	USF1	6	P22415
VKVNVTGTEFVVIED	VPS13D	2466	Q5THJ4
QIVEVDGISLVGVTQ	PPP1R9A	556	Q9ULJ8